Results 211 to 220 of about 3,578,919 (318)
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Impact of enteral feeding strategies on nosocomial <i>Clostridioides difficile</i> infection-induced diarrhea. [PDF]
Alasbly G +3 more
europepmc +1 more source
A Continuous Bi-Criteria Multimodal Traffic Assignment Problem: Formulation and Solution Algorithm
Yinchao Fan +4 more
openalex +1 more source
ABSTRACT Objective Super‐Refractory Status Epilepticus (SRSE) is a rare, life‐threatening neurological emergency with unclear etiology in many cases. Mitochondrial dysfunction, often due to disease‐causing genetic variants, is increasingly recognized as a cause, with each gene producing distinct pathophysiological mechanisms.
Pouria Mohammadi +2 more
wiley +1 more source
Comment on "Systematic Review of Continuous Glucose Monitor Accuracy in the Hypoglycemia Range for Non-Critical Care Ward Hospitalized People Living With Diabetes". [PDF]
Ahmad S, Arafat RA.
europepmc +1 more source
Fast, Continuous and Scalable Synthesis of Pt/Cu Nanoclusters
Jingyu Shi +4 more
openalex +1 more source
ABSTRACT Objective The Gold Coast criteria permit diagnosis of amyotrophic lateral sclerosis (ALS) even without upper motor neuron (UMN) signs. However, whether ALS patients with UMN signs (ALSwUMN) and those without (ALSwoUMN) share similar characteristics and prognoses remains unclear.
Hee‐Jae Jung +7 more
wiley +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source

